AptarGroup, Inc. (ATR)
NYSE: ATR · Real-Time Price · USD
121.91
-0.11 (-0.09%)
Dec 5, 2025, 4:00 PM EST - Market closed
AptarGroup Revenue
AptarGroup had revenue of $961.13M in the quarter ending September 30, 2025, with 5.70% growth. This brings the company's revenue in the last twelve months to $3.66B, up 2.50% year-over-year. In the year 2024, AptarGroup had annual revenue of $3.58B with 2.74% growth.
Revenue (ttm)
$3.66B
Revenue Growth
+2.50%
P/S Ratio
2.20
Revenue / Employee
$271,299
Employees
13,500
Market Cap
8.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.58B | 95.44M | 2.74% |
| Dec 31, 2023 | 3.49B | 165.20M | 4.97% |
| Dec 31, 2022 | 3.32B | 95.03M | 2.94% |
| Dec 31, 2021 | 3.23B | 297.88M | 10.17% |
| Dec 31, 2020 | 2.93B | 69.61M | 2.43% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ATR News
- 1 day ago - Aptar Named One of America's Most Responsible Companies by Newsweek for the Seventh Consecutive Year - Business Wire
- 3 days ago - Aptar Strengthens Latin America Footprint With Sommaplast Buy - Benzinga
- 12 days ago - Touchstone Mid Cap Fund Q3 2025 Portfolio Review - Seeking Alpha
- 17 days ago - AptarGroup, Inc. (ATR) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 24 days ago - Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025 - Business Wire
- 4 weeks ago - AptarGroup: Pharma Setback Creates Long-Term Opportunities - Seeking Alpha
- 5 weeks ago - AptarGroup, Inc. (ATR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Aptar Reports Third Quarter 2025 Results - Business Wire